BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6176601)

  • 1. The Langerhans cell.
    Thiers BH
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):519-22. PubMed ID: 6176601
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of dendritic cells in normal and abnormal human epidermis using monoclonal antibodies directed against Ia and HTA antigens.
    MacKie RM; Turbitt ML
    J Invest Dermatol; 1983 Sep; 81(3):216-20. PubMed ID: 6577071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Langerhans cells in cutaneous immunologic processes.
    Dezutter-Dambuant C
    Semin Dermatol; 1988 Jun; 7(2):163-70. PubMed ID: 3153438
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB.
    Toews GB; Bergstresser PR; Streilein JW
    J Immunol; 1980 Jan; 124(1):445-53. PubMed ID: 6153101
    [No Abstract]   [Full Text] [Related]  

  • 5. The Langerhans cell.
    Rowden G
    Crit Rev Immunol; 1981 Dec; 3(2):95-180. PubMed ID: 6178552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal Langerhans' cell densities influence survival in mycosis fungoides and Sézary syndrome.
    Meissner K; Michaelis K; Rehpenning W; Löning T
    Cancer; 1990 May; 65(9):2069-73. PubMed ID: 2196990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patch tests in Sézary syndrome and mycosis fungoides.
    Shupp DL; Winkelmann RK
    Contact Dermatitis; 1985 Sep; 13(3):180-5. PubMed ID: 4053598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATPase, antigens detected by monoclonal antibodies, ultrastructural characters: which is the best marker for Langerhans cells?
    De Panfilis G
    Arch Dermatol Res; 1983; 275(6):407-11. PubMed ID: 6229220
    [No Abstract]   [Full Text] [Related]  

  • 9. Subpopulations of human T lymphocytes. IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome.
    Gupta S; Safai B; Good RA
    Cell Immunol; 1978 Aug; 39(1):18-26. PubMed ID: 308846
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological markers of Langerhans' cells in mycosis fungoides skin lesions.
    Tjernlund U
    Acta Derm Venereol; 1982; 62(3):241-3. PubMed ID: 6179366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization.
    Bergstresser PR; Toews GB; Streilein JW
    J Invest Dermatol; 1980 Jul; 75(1):73-7. PubMed ID: 6446586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
    Meissner K; Löning T; Rehpenning W
    In Vivo; 1993; 7(3):277-80. PubMed ID: 8357970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values.
    Wood GS; Hong SR; Sasaki DT; Abel EA; Hoppe RT; Warnke RA; Morhenn VB
    J Am Acad Dermatol; 1990 Apr; 22(4):602-7. PubMed ID: 1690762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of Langerhans cells in genetically defined murine epidermal cell culture.
    Cohen RL; Chambers DA
    Br J Dermatol; 1984 Mar; 110(3):257-63. PubMed ID: 6230098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
    Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
    Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells.
    MacKie RM
    Lancet; 1981 Aug; 2(8241):283-5. PubMed ID: 6114327
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.
    Teunissen MB
    Histochem J; 1992 Oct; 24(10):697-716. PubMed ID: 1428996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity.
    Honda T; Nakajima S; Egawa G; Ogasawara K; Malissen B; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2010 May; 125(5):1154-1156.e2. PubMed ID: 20226508
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies in mycosis fungoides.
    Thiers BH
    J Am Acad Dermatol; 1982 Jul; 7(1):1-16. PubMed ID: 7050190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the Langerhans cells in contact allergy].
    Baer RL
    Z Hautkr; 1984 Sep; 59(18):1205-8. PubMed ID: 6437091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.